A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Part of paid clinical trials in Goodyear, Arizona.
- Sponsor
- Regeneron Pharmaceuticals
- Study ID
- NCT07154290
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Advanced/Metastatic Non-Small Cell Lung Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ubamatamab — DRUGAdministered per the protocol
- REGN7075 — DRUGAdministered per the protocol
- Sarilumab — DRUGAdministered per the protocol
Study Details
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metastatic Non-Small Cell Lung Cancer (NSCLC), and sarilumab, to evaluate to see if it can help with immune-related side effects from ubamatamab. The study is looking at: * How well ubamatamab and REGN7075 works * The side effects that ubamatamab and REGN7075 might cause * How much ubamatamab and REGN7075 is in the blood at different times * If the body makes antibodies to ubamatamab and/or REGN7075, this may cause the ubamatamab to not work as well
Key Dates
- Start date
- Mar 18, 2026
- Status verified
- May 2026
- Primary completion
- Jun 24, 2030
- Completion
- Jun 24, 2030
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1A
- Experimental: Arm 1B
- Experimental: Arm 1C
- Experimental: Arm 2A
- Experimental: Arm 2B
- Experimental: Arm 2C
Primary Outcome Measure
Objective response as assessed by the investigator per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 [ Time Frame: Up to 5 years ]
Central Contacts
- Clinical Trials Administrator844-734-6643
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cancer Treatment Centers of America, Phoenix | Goodyear | Arizona | 85338 | - |
| The City of Hope Orange County Lennar Foundation Cancer Center | Irvine | California | 92618 | - |
| Franciscan Health | Munster | Indiana | 46321 | - |
| University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | - |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | - |
Find similar trials in Goodyear, AZ
Related Studies
- Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersPHASE1/PHASE2 · Recruiting · Pfizer · Fayetteville, Arkansas